Research Paper Volume 14, Issue 21 pp 8700—8718

Identification and validation of a glycolysis-related gene signature for depicting clinical characteristics and its relationship with tumor immunity in patients with colon cancer

class="figure-viewer-img"

Figure 3. Text efficacy of the gene model in CC patients. (A) CC patient distribution according to the median risk score. (B) Kaplan–Meier analysis between the low- and high-risk groups. (C) ROC analysis of the risk score. (D) Model gene expression in the low- and high-risk groups. (E) The relationship between patient survival status and risk score. (F) PCA between the low- and high-risk groups.